Comparable companies
- BELGO-INTERNATIONAL RESEARCH APPLICATIONS en DEVELOPMENTGenk
- JVPCVosselaar
- ZC ANESREASint-Pieters-Leeuw
- TUDOR MEDGenk
- MEDISCH KABINET DR. E. WEYDTSTielt-Winge
Dr. Helena Van den Steene
ActiveFrom the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Dr. Helena Van den Steene has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €274,450 and a net result of €77,268. Equity is growing by about 48% per year across the filed financial years. Its solvency ranks better than 86% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 27-10-2022 Normal situation
- Legal form
- Private limited company
- Registered office
- Haachtsebaan 142 A, 3140 Keerbergen
- Activity
- Specialist medical practice NACE 86220
- Establishment units
- 2.340.000.680 2800 Mechelen, since 27-10-2022
- 2.384.340.073 2020 Antwerpen, since 27-10-2022
- Financial year end
- 31 December
- Peppol
- Reachable
How it is doing
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €99,924
- ▼ 33.1%
- Turnover
- ≈ €220,000
- estimated
- Profit
- €77,268
- ▼ 31.6%
- Equity
- €274,450
- ▲ 39.2%
- Total assets
- €300,140
- ▲ 26.9%
2025 accounts 185 days early
Filed on 27-01-2026PDF
Why 98raises risk1 change of registered office in 24 monthslowers riskLiquidity: current ratio 11.65, cash €272,883Sector: Human health activities (NACE 86)Equity €274,450 (91.4% of total assets)Show the evidence
Checked score
Score 2025
98
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 83% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency
100=
equity 91.4% of total assets
Liquidity
100+4
short-term debt 8.6% · cash 90.9%
Profitability
100=
return on assets 25.7%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: < 0.1%
12-2024: < 0.1%● unchanged vs 11-2024
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025highest value
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026lowest value
09-2026: < 0.1%● unchanged vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity ample (current ratio 11.65, compared with 5.98 in 2024, above the usual 1.5; short-term debt: 8.6% and cash: 90.9% of total assets), and 8.6% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 95% on liquidity, 80% on profitability and 76% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-01-2026, 185 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
185 days early
2024
29 days late
2023
13 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 3 accounts on average 48 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 August (3 of the last 3 filed years within 199 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
Key points
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 27-01-2026
- Annual accounts 2024filed on 29-08-2025
- Annual accounts 2023filed on 13-08-2024
Acts in the Belgian Official Gazette
- Registered officeact of 06-10-2026
- Incorporationact of 31-10-2022
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Dr. Helena Van den Steene
- What is the company number of Dr. Helena Van den Steene?
- 0792.962.330. In Belgium the VAT number is the company number with BE in front: BE 0792.962.330.
- Where is Dr. Helena Van den Steene based?
- The registered office is at Haachtsebaan 142 A, 3140 Keerbergen.Company details
- What does Dr. Helena Van den Steene do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Dr. Helena Van den Steene?
- Private limited company (BV).
- When was Dr. Helena Van den Steene founded?
- On 27-10-2022.
- Is Dr. Helena Van den Steene still active?
- Yes, Dr. Helena Van den Steene is an active enterprise in the KBO register.
- What is the turnover of Dr. Helena Van den Steene?
- ≈ €220,000 in financial year 2025. Estimated from the gross margin of €99,924: probably between €170,000 and €290,000, based on 32 comparable companies, NACE 862.Financials
- Is Dr. Helena Van den Steene profitable?
- In financial year 2025, Dr. Helena Van den Steene made a profit of €77,268.
- Where can I find the annual accounts of Dr. Helena Van den Steene?
- Dr. Helena Van den Steene filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
- When are the next annual accounts of Dr. Helena Van den Steene due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to Dr. Helena Van den Steene
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.